Astrazeneca Company News



Company:
Epic Code:
ISIN No:
StockName:
Group:
Sector:
Sub Sector:
Country:
Region:
Market:
Market Cap:

ASTRAZENECA PLC
AZN
GB0009895292
ORD USD0.25
4577
Pharmaceuticals & Biotechnology
Pharmaceuticals
UK
London
UK Main Market
41446.4387748 GBPm


Data as of 10:00 23/09/2009. Check director details and other company announcments at Astrazeneca Website .



RNS News for Astrazeneca





Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.



Latest Astrazeneca News



AstraZeneca plc (AZN) Earns "Reduce" Rating from HSBC Holdings plc
Sports Perspectives - 7 hours ago
AstraZeneca plc logo HSBC Holdings plc reiterated their reduce rating on shares of AstraZeneca plc (LON:AZN) in a report published on Monday, May 15th.
Astrazeneca Plc (NYSE:AZN) Technical and Valuation Says it All - ExpertGazette
Growth Analysis of Astrazeneca PLC (NYSE:AZN) - AppsforPCdaily

05/25/2017 02:30 AM


AstraZeneca PLC (AZN): Strong Industry, Solid Earnings Estimate Revisions
Nasdaq - May 23, 2017
One stock that might be an intriguing choice for investors right now is AstraZeneca PLCAZN . This is because this security in the Large Cap Pharmaceuticals space is seeing solid earnings estimate revision activity, and is in great company from a Zacks ...

05/23/2017 02:13 PM


AstraZeneca: No CV reduction in Bydureon trial
MarketWatch - May 23, 2017
LONDON--Pharmaceutical giant AstraZeneca PLC AZN, +0.28% said Tuesday that a recent trial of Bydureon met the primary safety objectives to not increase cardiovascular risk for patients with Type-2 diabetes.

05/23/2017 07:53 AM


AstraZeneca PLC (AZN) to Sell Rights to Metoprolol Based Treatments in Europe ...
StreetInsider.com - May 22, 2017
Recordati announced that it has entered into an agreement with AstraZeneca (NYSE: AZN) for the acquisition of the rights to Seloken┬«/Seloken┬« ZOK (metoprolol succinate) and associated Logimax┬« fixed dose combination (metoprolol succinate and ...
AstraZeneca, Recordati Enter Deal For Seloken; AstraZeneca To Receive $300 Mln - Nasdaq
AstraZeneca, Recordati agree Seloken rights deal - MarketWatch

05/22/2017 07:00 AM


AstraZeneca PLC 'one for the brave', but still a 'buy', according to leading ...
Proactive Investors UK - May 17, 2017
One for the brave, yes, certainly, but drugs giant AstraZeneca PLC (LON:AZN) is still a 'buy', according to City broker Liberum, which nudged up its price target following some key data and a sharp rise in the share price.
GlaxoSmithKline versus AstraZeneca: which share price will rise the fastest? - Investomania (blog)
Jefferies Group LLC Lowers AstraZeneca plc (AZN) Price Target to GBX 4700 - The Cerbat Gem

05/17/2017 08:07 AM


AstraZeneca Sues Executive After Rival Glaxo Lures Him Away
Bloomberg - May 15, 2017
AstraZeneca Plc filed a lawsuit in a London court against former executive Luke Miels saying he's in violation of his employment agreement, four months after rival drugmaker GlaxoSmithKline Plc announced it was poaching him to run its largest business.

05/15/2017 07:11 PM